Skip to main content
رجوع
Watch Compare

CervoMed Inc.

جودة البيانات: 100%
CRVO
Nasdaq Manufacturing Chemicals
KWD 4.00
▼ KWD 0.04 (-0.99%)
القيمة السوقية: 37.03 M
السعر
KWD 4.00
القيمة السوقية
37.03 M
نطاق اليوم
KWD 3.91 — KWD 4.11
نطاق 52 أسبوعًا
KWD 3.51 — KWD 13.13
حجم التداول
24,024
فتح KWD 4.03
متوسط 50 يوم / 200 يوم
KWD 4.55
12.01% below
متوسط 50 يوم / 200 يوم
KWD 7.24
44.73% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -23.45 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-58.86%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-90.72%
أقل من متوسط القطاع (-53.41%)
ROIC-65.08%
Net Margin-673.06%
Op. Margin-706.22%

الأمان

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

التقييم

PE (TTM)
-1.37
أعلى من متوسط القطاع (-1.48)
P/B Ratio1.42
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -1.4 -1.5
P/B 1.4 1.6
ROE % -90.7 -53.4
Net Margin % -673.1 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -58.86% Revenue Growth (3Y) -25.12%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.01 M Net Income (TTM) -26.97 M
ROE -90.72% ROA -78.51%
Gross Margin N/A Operating Margin -706.22%
Net Margin -673.06% Free Cash Flow (TTM) -23.45 M
ROIC -65.08% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 0.12
Working Capital N/A Tangible Book Value 26.01 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.37 Forward P/E N/A
P/B Ratio 1.42 P/S Ratio 9.24
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -63.32%
Market Cap 37.03 M Enterprise Value 27.60 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.43
FCF / Share -2.53 OCF / Share -2.53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86.96%
SBC-Adj. FCF -24.87 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.01 M 9.74 M 7.14 M — —
Net Income -26.97 M -16.29 M -2.17 M -15.59 M -24.10 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -28.29 M -18.23 M -7.81 M -15.97 M -24.68 M
EBITDA — — — — —
R&D Expenses 21.82 M 18.80 M 8.44 M 7.24 M 8.50 M
SG&A Expenses — — — — —
D&A — — — 0.0 93,416.0
Interest Expense — — 0.0 — —
Income Tax 0.0 — — 0.0 -443,893.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 22.88 M 43.08 M 9.97 M 22.64 M 37.84 M
Total Liabilities 4.66 M 3.88 M 2.60 M 2.42 M 2.93 M
Shareholders' Equity 18.22 M 39.20 M 7.38 M 20.22 M 34.91 M
Total Debt — — — — —
Cash & Equivalents 8.24 M 9.00 M 7.79 M 10.11 M 37.31 M
Current Assets 22.88 M 43.08 M 9.96 M 22.64 M 37.82 M
Current Liabilities 4.66 M — — — 2.93 M